- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
SMS Pharmaceuticals has proposed a final dividend of Re. 0.40 per share (40% on face value) for FY 2024-25, pending shareholder approval at the AGM. Record and payment dates will be announced later. The company reported a consolidated net profit of ₹69.14 Cr, up from ₹49.83 Cr last year, with EPS rising to ₹8.16. Expansion plans include a ₹10 Cr investment in a subsidiary and setting up a new wholly owned pharma entity, signaling growth focus ahead.